PRESS RELEASE TiGenix strengthens US operations with senior appointments- Dr. Gregory Gordon appointed as Head of Medical Department (U.S.)- Annette Valles-Sukkar appointed as Associate Director, Clinical ProjectLeuven (BELGIUM) - September 12, 2017, 7:00h CEST - TiGenix NV (Euronext Brussels and...Read More
(TheNewswire) Toronto, Ontario / TheNewswire / September 8, 2017 - Toachi Mining Inc., ("Toachi" or the "Company") (TSX-V: TIM) announces that Nick Tintor, the Company's President and CEO, Co-Founder, since its inception in 2015, will transition the position of President and CEO to Jonathan G...Read More
TORONTO, Sept.06, 2017(GLOBE NEWSWIRE) -- At the request of IIROC, Altai Resources Inc. (TSX VENTURE:ATI) (US SEC Rule 12g3-2(b) File # 82-2950) ("Altai" or the "Company") wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would acco...Read More
TSX.V: TIGOTCMKTS: NFRGF Frankfurt: 8N61 VANCOUVER, Sept. 5, 2017 /CNW/ - Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: NFRGF) ("Triumph Gold" or the "Company") applauds the announcement made on September 2, 2017 by Prime Minister Justin Trudeau and Yukon Premier Sandy Silver committing more than...Read More
PRESS RELEASE TiGenix obtains commercial production license for expanded manufacturing facility- Provides capacity for potential European commercial roll out of investigational stem cell therapy, Cx601 - Expanded facility also secures manufacturing for other pipeline products...Read More
Toronto, Ontario--(Newsfile Corp. - August 22, 2017) - Eurotin Inc. (TSXV: TIN) ("Eurotin" or the "Company"), is pleased to announce that it has filed its first quarter unaudited condensed interim consolidated financial statements and related management's discussion and analysis for the three mont...Read More
(TheNewswire) Toronto, Ontario / TheNewswire / August 10, 2017 - Toachi Mining Inc. ("Toachi" or the "Company") (TSX-V: TIM) announces that the Board of Directors of the Company has approved the grant of an aggregate of 1,300,000 stock options (the "Options") to eligible participants of the Com...Read More
(TheNewswire) Toronto, Ontario / TheNewswire / July 31, 2017 - Toachi Mining Inc., ("Toachi" or the "Company") (TSX-V: TIM) is pleased to announce results from on-going drilling at its La Plata gold-rich volcanogenic massive sulphide ("VMS") project in Ecuador. Program Highlights -Hole...Read More
(TheNewswire) Maiden 43-101 Resource Estimate Study Under Way Toronto, Ontario / TheNewswire / July 10, 2017 - Toachi Mining Inc., ("Toachi" or the "Company") (TSX-V: TIM) is pleased to announce results from on-going drilling at its La Plata gold-rich volcanogenic massive sulphide ("...Read More
TORONTO, ONTARIO--(Marketwired - July 10, 2017) - Altai Resources Inc. (TSX VENTURE:ATI)(US SEC Rule 12g3-2(b) File # 82-2950) (the "Company") is pleased to announce that at its annual general meeting of the shareholders held on July 7, 2017 in Toronto (the "Meeting"), Dr. Niyazi...Read More
Toronto, Ontario--(Newsfile Corp. - June 30, 2017) - Eurotin Inc. (TSXV: TIN) ("Eurotin" or the "Company"), is pleased to announce that it has filed its annual audited financial statements and related management's discussion and analysis for the fiscal year ended March 31, 2017.Both are available on...Read More
PRESS RELEASE TiGenix opens US headquarters in Cambridge, MA Decision follows NASDAQ IPO in 2016 and the launch of the global phase III trial for Cx601 Operations to be based in Cambridge at heart of Boston area biotech hub High-level team of professionals being recruited to support clinical an...Read More
PRESS RELEASEregulated information Leuven (BELGIUM) - June 12, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-derived, stem cells to develop novel therapies...Read More
PRESS RELEASE TiGenix Launches Global Phase III Trial for Cx601Leuven (BELGIUM) - June 13, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-derived, stem cells t...Read More
PRESS RELEASE TiGenix Partners with U.S. and European Patient Advocacy Groups Focused on Crohn's Disease and Ulcerative Colitis- Joins the Crohn's and Colitis Foundation's President's Corporate Circle- Signs Sponsorship Agreement with the European Federation of Crohn's a...Read More
PRESS RELEASE Takeda and TiGenix announce that Swissmedic has accepted for review the file on Cx601 for the treatment of complex perianal fistulas in Crohn's disease patientsPf??ffikon, SZ, June 20, 2017, and Leuven, Belgium, June 20, 2017 - Takeda Pharma AG (TSE: 4502) ("Takeda") and TiGen...Read More
PRESS RELEASE TiGenix to present at the 7th TERMIS-EU Conference in Davos, SwitzerlandLeuven (BELGIUM) - June 23, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or don...Read More
(TheNewswire) Toronto, Ontario / TheNewswire / May 10, 2017 - Toachi Mining Inc., ("Toachi" or the "Company") (TSX-V: TIM) is pleased to announce that Mr. Eberhard ("Ebe") Scherkus has been appointed to the Company's Board of Directors. Mr. Scherkus is one of Canada's most prominent mining e...Read More
(TheNewswire) Toronto, Ontario / TheNewswire / May 18, 2017 - Toachi Mining Inc. ("Toachi" or the "Company") (TSX-V: TIM) announces that the Board of Directors of the Company has approved the grant of 250,000 stock options (the "Options") to Mr. Eberhard "Ebe" Scherkus. Mr. Scherkus was app...Read More
(TheNewswire) Toronto, Ontario / TheNewswire / May 23, 2017 - Toachi Mining Inc., (TSX-V: TIM) ("Toachi" or the "Company") is pleased to announce that it intends to complete a non-brokered private placement to raise up to $3.5 million in gross proceeds (the "Offering"). The Offering will consist...Read More